The Alzheimers Disease Center (ADC) at New York University School of Medicine is structured as an Alzheimers Disease Core Center (ADCC). It provides core resources and pilot study support to a comprehensive multi-disciplinary research program on Alzheimers Disease (AD). Investigators at the NYS Institute for Basic Research (IBR), the Bellevue Hospital Center (BHC), the Nathan Kline Institute (NKI) and other New York City area facilities are also participating. The ADCC encompasses physical, patient and laboratory resources, relevant research projects and pilot studies and an established group of investigators committed to studying AD. The general goal of the Center is to integrate, expand and facilitate innovative basic and clinical research to extend knowledge about the pathophysiology, early diagnosis and treatments of AD. Patients with AD and related disorders, subjects with mild cognitive impairment and normal elderly subjects are studied longitudinally through postmortem. AD research served by the ADCC include molecular and cellular biology; neuropathologic-clinical correlation; in vivo neuroimaging; clinical symptomatology and longitudinal course; cognition and psychopharmacology; and AD caregiver studies. The ADCC is supervised by a Director and seven Associate leaders who serve on an Executive Committee, an Institutional Steering Committee and an External Scientific Advisory Committee. Cores support consist of Administrative, Clinical (including CSF and Serum/DNA Banks, and a Satellite Diagnostic and Treatment Center [SDTC] focusing on minority recruitment at BHC), Neuroimaging, Neuropathology (including a morphometry component at IBR, and a proposed new satellite at Sun Health Research Institute [SunCity, Az]), Data Management, Caregiver and Education and Information Transfer. Each year, three pilot studies are directly supported by the ADCC. In addition, extensive current research receiving primary support from other sources is facilitated by ADCC core facilities through utilization of core resources. During the current funding period, the core resources have been maintained and the base of AD research at NYU has been expanded, in part through recruitment of established investigators. The new Caregiver core has been added to the Center, and there are increased collaborations with other ADCs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG008051-11S1
Application #
6334224
Study Section
Special Emphasis Panel (ZAG1 (J1))
Program Officer
Phelps, Creighton H
Project Start
1990-08-20
Project End
2005-04-30
Budget Start
2000-08-15
Budget End
2001-04-30
Support Year
11
Fiscal Year
2000
Total Cost
$48,107
Indirect Cost
Name
New York University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Herline, Krystal; Prelli, Frances; Mehta, Pankaj et al. (2018) Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Alzheimers Res Ther 10:54
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Goñi, Fernando; Martá-Ariza, Mitchell; Herline, Krystal et al. (2018) Anti-?-sheet conformation monoclonal antibody reduces tau and A? oligomer pathology in an Alzheimer's disease model. Alzheimers Res Ther 10:10
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104

Showing the most recent 10 out of 604 publications